An FDA advisory panel has officially endorsed the Pfizer COVID-19 vaccine for children ages 5-11. The panel made a unanimous decision on Tuesday, which now goes to the FDA for its final ruling, due sometime in the coming days. If approved, the vaccine would be a smaller dose than the one given to adults – just 10 micrograms compared to 30 in the full vaccine. Just like the adult vaccine, it would be given in two doses, three weeks apart.
